• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: EDWARDS LIFESCIENCES LLC EDWARDS INSPIRIS RESILIA AORTIC VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

EDWARDS LIFESCIENCES LLC EDWARDS INSPIRIS RESILIA AORTIC VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE Back to Search Results
Model Number 11500A
Device Problems Microbial Contamination of Device (2303); Insufficient Information (3190)
Patient Problems Endocarditis (1834); Insufficient Information (4580)
Event Date 12/08/2023
Event Type  Injury  
Manufacturer Narrative
The investigation is still in progress; therefore, a conclusion has yet to be established.A supplemental report will be submitted accordingly upon investigation completion.Edwards will continue to review and monitor all reported events.Trends are monitored on a monthly basis and if action is required, appropriate investigation will be performed.
 
Event Description
It was learned through implant patient registry that a 25mm 11500a aortic valve in aortic position was explanted after an implant duration of two (2) years, three (3) months due to unknown reasons.The replacement is a 25mm 11060a konect resilia valved conduit.Edwards lifesciences maintains an implant patient registry.This registry is a patient tracking mechanism for serialized edwards implantable devices (bioprosthetic heart valves and annuloplasty rings), rather than a true post-market surveillance registry.Through the registry, edwards is notified when these devices are implanted.In addition, patient and/or device status may be reported to the registry via the implantation data cards.The information is received from various sources (e.G.Surgeon, hospital, and patient family members) and is not received in the form of a conventional "customer complaint".The information reported may or may not be related to the edwards device.
 
Manufacturer Narrative
H10: additional manufacturer narrative: updated sections: h6 (type of investigation).H11: corrective data: based on the additional information obtained, this event is no longer considered reportable, and this correction is being submitted.All pertinent information available to edwards lifesciences has been submitted.
 
Event Description
It was learned through implant patient registry and medical records that a 25mm 11500a aortic valve in aortic position was explanted after an implant duration of two (2) years, three (3) months due aortic root abscess (endocarditis).The replacement is a 25mm 11060a konect resilia valved conduit and patient was transferred to a monitored bed in good condition.Unfortunately, the patient deceased on (b)(6) 2023 due to multi organ involvement.Per medical record, the patient had cardiopulmonary arrest due to multiorgan involvement including bacterial endocarditis, acute hypoxemic respiratory failure, and stroke due to bilateral cerebral infarctions also caused by bacterial endocarditis.Pathology report revealed aortic valve with adherent tissue demonstrating acute inflammation and fibrin deposition consistent with blood clot.The patient was recently discharged on (b)(6) 2023 for septic shock secondary to streptococcus mitis causing endocarditis on outpatient iv rocephin who follows with renown infectious disease was referred to the er on (b)(6) 2023 for worsening renal function.Patient was found to have prosthetic aortic valve endocarditis and he underwent aortic root replacement on (b)(6) 2023.On (b)(6) 2023, patient also underwent permanent pacemaker implantation for complete heart block.On (b)(6) 2023, patient was transferred to imcu since he did not show signs of clinical improvement in the setting of multi organ involvement.On (b)(6) 2023, the patient's family requested that he is placed in comfort care.The patient received morphine and benzodiazepine for discomfort and passed away.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EDWARDS INSPIRIS RESILIA AORTIC VALVE
Type of Device
HEART-VALVE, NON-ALLOGRAFT TISSUE
Manufacturer (Section D)
EDWARDS LIFESCIENCES LLC
1 edwards way
irvine CA 92614
Manufacturer (Section G)
EDWARDS LIFESCIENCES LLC
1 edwards way
irvine CA 92614
Manufacturer Contact
saurav singh
1 edwards way
mle fl2- office m2013
irvine, CA 92614
9492506615
MDR Report Key18519863
MDR Text Key332944289
Report Number2015691-2024-00420
Device Sequence Number1
Product Code LWR
UDI-Device Identifier00690103194999
UDI-Public(01)00690103194999(17)250421(11)210422217728350
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P150048
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Health Professional
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 03/07/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/16/2024
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model Number11500A
Device Catalogue NumberN/A
Device Lot NumberN/A
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Date Manufacturer Received02/29/2024
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured04/22/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention; Hospitalization; Life Threatening;
Patient Age55 YR
Patient SexMale
-
-